These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Baggio L; Kieffer TJ; Drucker DJ Endocrinology; 2000 Oct; 141(10):3703-9. PubMed ID: 11014225 [TBL] [Abstract][Full Text] [Related]
8. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats. Higuchi N; Hira T; Yamada N; Hara H Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598 [TBL] [Abstract][Full Text] [Related]
10. GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys. Lu SC; Chen M; Atangan L; Killion EA; Komorowski R; Cheng Y; Netirojjanakul C; Falsey JR; Stolina M; Dwyer D; Hale C; Stanislaus S; Hager T; Thomas VA; Harrold JM; Lloyd DJ; Véniant MM Cell Rep Med; 2021 May; 2(5):100263. PubMed ID: 34095876 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor. Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578 [TBL] [Abstract][Full Text] [Related]
12. Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists. Naylor J; Suckow AT; Seth A; Baker DJ; Sermadiras I; Ravn P; Howes R; Li J; Snaith MR; Coghlan MP; Hornigold DC Biochem J; 2016 Sep; 473(18):2881-91. PubMed ID: 27422784 [TBL] [Abstract][Full Text] [Related]